New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Fasting plasma glucose (FPG), age, body mass index (BMI), and male sex are all associated with development of diabetes.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

People with type 1 diabetes risk getting kidney disease if they engage in so-called yo-yo dieting, a team of French doctors warns.The danger applies regardless of a patient's weight or other ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

"A loss of drive power can increase the risk of a crash. A loss of park function can cause an unintended vehicle rollaway, which can increase the risk of a crash or injury." Though drivers may ...

Type 2 diabetes affects over 400 million adults worldwide. It's not necessarily a permanent condition and can be reversed by intensive weight management, but the most effective methods of weight loss ...